Whole-time Director Ravindra Salaskar resigns; continues as CFO
SAROJA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Ravindra Shivaji Salaskar resigned as Whole-time Director of Saroja Pharma Industries India effective October 6, 2026, citing personal reasons and the need to realign professional commitments. Importantly, he clarified that his resignation covers only the Director and Whole-time Director role. He will continue as Chief Financial Officer (CFO), so finance leadership remains in place. He has assured a smooth transition of board responsibilities.
Board seat vacated but CFO role unchanged, limiting disruption. Investors should watch for a successor appointment announcement for the Director post.